ESC 365 - Circulating exosomes from patients with coronary syndrome inhibit angiogenesis and trigger inflammatory pathways in vitro through TLR activation

ESC Premium Access

Circulating exosomes from patients with coronary syndrome inhibit angiogenesis and trigger inflammatory pathways in vitro through TLR activation

Session: Exosomes: new players in cardiovascular disease

Topic: Microvesicles, Exosomes

Speaker: Doctor J. Bobi (Rotterdam, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Joaquim Bobi

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

4 more presentations in this session

Exosomes: new players in cardiovascular disease - Current knowledge

Speaker: Professor S. Davidson (London, GB)

The RNA-binding protein hnRNPU mediates microvesicle based microRNA-24 transfer and controls microvesicle function

Speaker: Doctor A. Zietzer (Bonn, DE)

Neovascularization potential of exosomes derived from blood outgrowth endothelial cells in ischemic cardiomyopathy.

Speaker: Doctor A. Wibowo (Bandung, ID)

Extracellular vesicles as therapeutic systems.

Speaker: Professor J. Sluijter (Utrecht, NL)

Access the full session

Exosomes: new players in cardiovascular disease

Speakers: Doctor J. Bobi, Professor S. Davidson, Doctor A. Zietzer, Doctor A. Wibowo, Professor J. Sluijter

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources